ArticleInternational journal of retina and vitreous2023

Intravitreal bevacizumab plus propranolol for neovascular age-related macular degeneration (the BEVALOL study): a phase I clinical trial.

José Edísio da Silva Tavares Neto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.